📑Suministro de equipos para la realizacion de aferesis
Procurement process summary
This process is to purchase Suministro de equipos para la realizacion de aferesis.
This contract was awarded by 🇪🇸 Gerencia de Asistencia Sanitaria de Palencia for an amount of EUR 130,000 to 1 supplier. It was published on 2022-06-09 through direct
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇸 Gerencia de Asistencia Sanitaria de Palencia Buying unitnot reported Publication date2022-06-09 Contest statusnot reported DescriptionHasta 24 mesesAwards
This award was granted to ADACYTE THERAPEUTICS, S.L. by Gerencia de Asistencia Sanitaria de Palencia for an amount of EUR 130,000. The procurement process was conducted through direct for the category of goods. The award was granted on 2022-08-25. This is award number 1.
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇪🇸 ADACYTE THERAPEUTICS, S.L. | EUR 130,000 | 2022-08-25 | 1 |
Market context and opportunities
The execution of this contract allows the entity Gerencia de Asistencia Sanitaria de Palencia to fulfill its public service objectives efficiently.
The direct purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberES_ocds-70d2nz-8771ef3e-668e-432d-ba26-d05f5c95d189-award-1Publication date2022-06-09Contract datenot reportedAward date2022-08-25CategoriesgoodsPurchase modalitydirectMethod details3Statusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
